Clinical Trials Browser

Phase 1 × Completed × LY3214996 × Clear all

NCT04081259 2025-05-08

LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy

Phase 1 Completed

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT02857270 2022-11-22

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Phase 1 Completed

DermatologicGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms